映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09606 映恩生物-B

交易中 12-05 11:09:01

335.000

-7.800

-2.28%

最高344.000	最低329.800	成交量24.36万
今开340.200	昨收342.800	日振幅4.14%
总市值297.75亿	流通市值297.75亿	总股本8,888万
成交额8,149万	换手率0.27%	流通股本8,888万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":335,"timestamp":1764904120036,"preClose":342.8,"halted":0,"volume":243600,"delay":0,"floatShares":88879200,"shares":88879200,"eps":-144.59828458253875,"marketStatus":"交易中","change":-7.8,"latestTime":"12-05 11:09:01","open":340.2,"high":344,"low":329.8,"amount":81487980,"amplitude":0.041424,"askPrice":335,"askSize":100,"bidPrice":334,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":-125.44160068472667,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1764907200000},"marketStatusCode":2,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":342.8,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.354077,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"1162267990","title":"映恩生物（09606）公布11月股份变动月报表，新增584,950股","url":"https://stock-news.laohu8.com/highlight/detail?id=1162267990","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162267990?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:51","pubTimestamp":1764838261,"startTime":"0","endTime":"0","summary":"映恩生物于2025年12月4日发布2025年11月股份变动月报表。报告期内，该公司法定股本维持在2亿股，面值0.0001美元，总额保持20,000美元不变。据月报显示，截至2025年11月30日，公司已发行普通股由上月底的88,294,264股增至88,879,214股，增加584,950股。本次新增发行主要来自首次公开发售前股权激励计划的行使，行使期权共计584,950股，所得资金约为港币3,555,743.85。月报同时披露，报告期内公司无股份回购及库存股变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":0},{"id":"2588002989","title":"每日卖空追踪 | 映恩生物-B 12月04日卖空量成交1.31万股，卖空比例为2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002989?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837041,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月04日，涨5.28%，卖空量成交1.31万股，较上一交易日减少69.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163627a72359cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163627a72359cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD","BK1161","LU2543165471.USD"],"gpt_icon":0},{"id":"2588002605","title":"映恩生物-B12月04日主力净流入1105.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002605?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836115,"startTime":"0","endTime":"0","summary":"12月04日, 映恩生物-B股价涨5.28%，报收342.80元，成交金额2.2亿元，换手率0.73%，振幅4.98%，量比0.98。映恩生物-B今日主力资金净流入1105.8万元，上一交易日主力净流出453.3万元。该股近5个交易日下跌1.61%，主力资金累计净流入1389.4万元；近20日主力资金累计净流入7796.5万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161616952a7129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161616952a7129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09606","LU2543165471.USD","BK1161","HK0000252152.HKD","HK0000500386.USD"],"gpt_icon":0},{"id":"2588026170","title":"映恩生物创新药DB-1324获FDA IND批准，即将在美国启动临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2588026170","media":"制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588026170?lang=zh_cn&edition=full","pubTime":"2025-12-04 14:13","pubTimestamp":1764828826,"startTime":"0","endTime":"0","summary":"近日 ，映恩生物宣布，公司自主研发的新一代抗体偶联药物DB-1324新药临床试验申请已获得美国食品药品监督管理局的批准，即将在美国启动临床试验。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过20个国家开展多个全球多中心临床试验，入组超过2,700名患者。同时，映恩生物与全球制药公司和顶尖创新药企达成多项海外授权合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204141351a4cbf115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204141351a4cbf115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000252160.HKD","HK0000500386.USD","09606","HK0000252152.HKD","LU2543165471.USD","BK1574","06978"],"gpt_icon":0},{"id":"2588034954","title":"每日卖空追踪 | 映恩生物-B 12月02日卖空量成交3.31万股，卖空比例为7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588034954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588034954?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664238,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月02日，跌0.53%，卖空量成交3.31万股，较上一交易日减少57.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163555a71ebfd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163555a71ebfd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09606","HK0000500386.USD","HK0000252152.HKD","BK1161","LU2543165471.USD"],"gpt_icon":0},{"id":"2588709175","title":"智通港股通资金流向统计(T+2)|12月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588709175","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588709175?lang=zh_cn&edition=full","pubTime":"2025-12-02 07:31","pubTimestamp":1764631861,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月27日,阿里巴巴-W、泡泡玛特、招商银行南向资金净流入金额位列市场前三，分别净流入9.11 亿、4.42 亿、3.66 亿小米集团-W、紫金矿业、腾讯控股南向资金净流出金额位列市场前三，分别净流出-6.88 亿、-4.22 亿、-2.61 亿在净流入比方面，四川成渝高速公路、中国海外宏洋集团、中国外运以68.85%、68.33%、65.67%位列市场前三。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01361","00081","06818","02255","00762","03877","HBBD.SI","02169","00548","03441","01860","02555","HTCD.SI","00941","02888","09992","03347","09606","09926","80883","03323","HXXD.SI","03033","01186","00777","06690","HMTD.SI","02057","09988","81810","06969","STAN.UK","00598","02899","81024","00107","00173","KSTmain","03143","02628","06198","03968"],"gpt_icon":1},{"id":"2586389271","title":"兴证国际：首予映恩生物-B(09606)“增持”评级 公司立足创新持续引领下一代ADC研发浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2586389271","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586389271?lang=zh_cn&edition=full","pubTime":"2025-11-28 09:08","pubTimestamp":1764292136,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兴证国际发布研报称，首次覆盖，给予映恩生物-B“增持”评级，映恩生物聚焦 ADC 赛道领域，借助与 BioNTech 等全球领先药企的合作，以中国速度推进全球多中心临床快速布局，在 ADC 领域占据有利的竞争身位。兴证国际主要观点如下：近期事件2025 年 10 月 23 日公司举办研发日，介绍公司 ADC 产品管线近期进展以及未来发展方向。2025 年 11 月 14 日公司自身免疫 ADC 产品管线 DB-2304用于系统性红斑狼疮临床全球 1/2a期研究的 2a 期部分完成首例患者给药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","06058","09606"],"gpt_icon":0},{"id":"2586280342","title":"映恩生物-B盘中异动 股价大涨5.03%报342.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586280342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586280342?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:44","pubTimestamp":1764121472,"startTime":"0","endTime":"0","summary":"2025年11月26日早盘09时44分，映恩生物-B股票出现波动，股价大幅上涨5.03%。截至发稿，该股报342.600港元/股，成交量12.843万股，换手率0.15%，振幅5.40%。资金方面，该股资金流入2744.67万港元，流出1271.06万港元。映恩生物-B股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，歌礼制药-B、映恩生物-B、加科思-B涨幅较大，振幅较大的相关个股有华康生物医学、拨康视云-B、荣昌生物，振幅分别为10.00%、7.09%、6.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126094432951aa04d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126094432951aa04d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","HK0000252160.HKD","BK1161","09606","LU2543165471.USD","HK0000500386.USD"],"gpt_icon":0},{"id":"2586249223","title":"每日卖空追踪 | 映恩生物-B 11月24日卖空量成交6900股，卖空比例为0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586249223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586249223?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:30","pubTimestamp":1763973039,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间11月24日，涨4.03%，卖空量成交6900股，较上一交易日减少74.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112416360295171ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112416360295171ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD","LU2543165471.USD","09606"],"gpt_icon":0},{"id":"2585493780","title":"映恩生物-B11月24日主力净流入991.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585493780?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:15","pubTimestamp":1763972157,"startTime":"0","endTime":"0","summary":"11月24日, 映恩生物-B股价涨4.03%，报收325.20元，成交金额3.4亿元，换手率1.20%，振幅5.50%，量比1.27。映恩生物-B今日主力资金净流入991.4万元，上一交易日主力净流出391.2万元。该股近5个交易日下跌5.13%，主力资金累计净流出664.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1.0亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124162213977c17f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124162213977c17f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","BK1161","09606","HK0000252160.HKD"],"gpt_icon":0},{"id":"2585163091","title":"每日卖空追踪 | 映恩生物-B 11月20日卖空量成交2.41万股，卖空比例为4.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585163091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585163091?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627439,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间11月20日，涨2.17%，卖空量成交2.41万股，较上一交易日增加62.84%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016375797753864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016375797753864&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","HK0000500386.USD","LU2543165471.USD","09606","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2584977237","title":"智通港股通占比异动统计|11月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=2584977237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584977237?lang=zh_cn&edition=full","pubTime":"2025-11-20 08:36","pubTimestamp":1763598980,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年11月19日披露数据，国富氢能、龙蟠科技、盈富基金港股通持股占比增加值最大，分别增加5.52%、2.85%、2.53%；三花智控、中兴通讯、金风科技港股通持股占比减少值最大，分别减少-0.83%、-0.66%、-0.60%。在最近有统计数据的5个交易日内，国富氢能、巨星传奇、亿华通港股通持股占比增加值最大，分别增加7.02%、4.80%、4.15%；恒生中国企业、重庆钢铁股份、金风科技港股通持股占比减少值最大，分别减少-3.11%、-2.84%、-1.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06616","02402","02465","02600","02648","02469","00525","06683","00956","00777","01138","01057","01341","06127","00354","03866","06693","01478","09606","01877","03759","00038","00553","00874","01385","01071","00666","00921","01375","00568","02631","09696","01635","01282","02208","00763","01858","01072","00696","00187","00412","02050","02603","01053","02582","00826","06865","06680"],"gpt_icon":1},{"id":"2585651155","title":"创新药港股AB面","url":"https://stock-news.laohu8.com/highlight/detail?id=2585651155","media":"深蓝观","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585651155?lang=zh_cn&edition=full","pubTime":"2025-11-20 07:14","pubTimestamp":1763594040,"startTime":"0","endTime":"0","summary":"在2025年1月份的JP摩根医疗健康大会上，正好是中国创新药资产被全世界看见的时刻，会场上放眼望去，目之所及都是中国面孔。不过短短几个月，二级市场IPO开闸，3月份国际资金回流中国股市，港股IPO张灯结彩，2月份，一些即将上市的biotech又面临基石投资难求的困境，2个月后，基石又被疯抢。-02-繁华下的异动前几年被国内商业化、外资撤出等因素压下来的创新药的繁荣，2025年下半年，在港股打开一扇门后，被压抑的火苗，熊熊燃烧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120075224950f62e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120075224950f62e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09606","09887","06978","BK1161"],"gpt_icon":0},{"id":"2584967730","title":"智通港股通持股解析|11月19日","url":"https://stock-news.laohu8.com/highlight/detail?id=2584967730","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584967730?lang=zh_cn&edition=full","pubTime":"2025-11-19 08:30","pubTimestamp":1763512201,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年11月18日披露数据，中国电信、绿色动力环保、中远海能位居港股通持股比例前3位，分别为72.20%、69.27%、69.13%。此外，小米集团－Ｗ、腾讯控股、工商银行在最近有统计数据的5个交易日内，持股额增幅最大，分别为+27.92亿元、+13.92亿元、+12.90亿元;盈富基金、恒生中国企业、华虹半导体在最近有统计数据的5个交易日内，持股额减幅最大，分别为-62.67亿元、-21.20亿元、-9.12亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03143","02318","01088","03759","METmain","01398","03678","01456","02423","HTCD.SI","01109","00874","00763","03033","PNGAY","GELYY","82318","00728","01341","00175","01065","01330","EVS.SI","01138","01209","02196","02828","09606","01108","06160","00939","80175","01288","00568","HMTD.SI","01635","01375","01776","HPAD.SI","02238","00700","03145","03958","MCHmain"],"gpt_icon":1},{"id":"2584957558","title":"每日卖空追踪 | 映恩生物-B 11月18日卖空量成交2.57万股，卖空比例为3.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584957558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584957558?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:30","pubTimestamp":1763454638,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间11月18日，跌3.15%，卖空量成交2.57万股，较上一交易日减少78.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118163624a7016179&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118163624a7016179&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","HK0000252160.HKD","09606","BK1161","HK0000500386.USD","LU2543165471.USD"],"gpt_icon":0},{"id":"2584957584","title":"映恩生物-B11月18日主力净流出155.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2584957584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584957584?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:15","pubTimestamp":1763453745,"startTime":"0","endTime":"0","summary":"11月18日, 映恩生物-B股价跌3.15%，报收332.40元，成交金额2.5亿元，换手率0.85%，振幅4.72%，量比0.45。映恩生物-B今日主力资金净流出155.5万元，上一交易日主力净流入1792.8万元。该股近5个交易日上涨11.85%，主力资金累计净流入3267.7万元；近20日主力资金累计净流入7480.1万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181620169770b483&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181620169770b483&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","09606","LU2543165471.USD","BK1161","HK0000252152.HKD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2583619476","title":"医药生物行业定期报告：资金明显回流医药板块 关注有变化的佰仁医疗！","url":"https://stock-news.laohu8.com/highlight/detail?id=2583619476","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583619476?lang=zh_cn&edition=full","pubTime":"2025-11-16 00:00","pubTimestamp":1763222400,"startTime":"0","endTime":"0","summary":"新品连续上市放量+瓣膜集采预期，动物源胶原蛋白上市在即，关注佰仁医疗。2）佰仁医疗：①新品连续上市，25 年12 款产品审评中，为公司成立来提交最多一年；收入端已连续4 季度收入30%增速，预计未来保持高增态势。③布局三款动物源胶原蛋白，其中I 型已进入注册审查阶段，预计近期有望获批。供不应求现状，有望上市后即受到需求拉动放量。收入高增有支撑，动物源胶原蛋白上市催化，26 年增长有望提速，建议关注佰仁医疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116184631a6fcfc7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116184631a6fcfc7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000500386.USD","09939","HK0000252160.HKD","BK1515","09606","LU2543165471.USD","01801","HK0000252152.HKD","BK1574"],"gpt_icon":0},{"id":"2583537049","title":"映恩生物-B(09606.HK)再涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583537049","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583537049?lang=zh_cn&edition=full","pubTime":"2025-11-13 13:47","pubTimestamp":1763012865,"startTime":"0","endTime":"0","summary":"每经AI快讯，映恩生物-B(09606.HK)再涨超8%，截至发稿，涨7.36%，报329.6港元，成交额6.58亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511133563428291.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511133563428291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000252152.HKD","09606","LU2543165471.USD","HK0000500386.USD","BK1161","HK0000252160.HKD"],"gpt_icon":0},{"id":"2583537658","title":"港股异动 | 映恩生物-B(09606)再涨超8% DB-1418获FDA授予快速通道资格 同时在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2583537658","media":"智通财经","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583537658?lang=zh_cn&edition=full","pubTime":"2025-11-13 13:34","pubTimestamp":1763012084,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B再涨超8%，截至发稿，涨7.36%，报329.6港元，成交额6.58亿港元。消息面上，11月11日，映恩生物宣布DB-1418获美国FDA授予快速通道资格，针对不可切除的局部晚期或转移性非小细胞肺癌患者的治疗适应症。根据协议，映恩生物将获得5000万美元的首付款，并有资格获得高达11.5亿美元的开发、注册及商业化里程碑付款。同时，映恩生物还有资格获得Avenzo在其区域内的销售收入分成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4118","LU2543165471.USD","BK4566","09606","HK0000500386.USD","HK0000252160.HKD","BK4552","HK0000252152.HKD","DB","BK4585","BK4588"],"gpt_icon":0},{"id":"1139577547","title":"港股生物医药股逆势走高！百济神州涨超7%，百奥赛图-B涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139577547","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139577547?lang=zh_cn&edition=full","pubTime":"2025-11-13 09:42","pubTimestamp":1762998120,"startTime":"0","endTime":"0","summary":"11月13日，港股生物医药股逆势走高，$百济神州(06160)$涨超7%，$百奥赛图-B(02315)$涨超6%，$映恩生物-B(09606)$涨超5%，$三生制药(01530)$、$信达生物(01801)$、$来凯医药-B(02105)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","ONC","02315","LU2097828805.USD","LU0588546209.SGD","LU0455707207.USD","LU0502904849.HKD","LU2097828631.EUR","LU0307460666.USD","BK1593","LU1969619763.USD","01801","BK4139","LU2097828714.EUR","06160","09939","HK0000252160.HKD","BK4526","BK1588","BK1500","HK0000252152.HKD","LU2097828474.EUR","BK1589","LU2242644610.SGD","BK1161","02105","LU1251922891.USD","LU1303224171.USD","BK1583","LU1770034418.SGD","LU2328871848.SGD","HK0000500386.USD","09606","LU2543165471.USD","LU2097828557.USD","01530","HK0000165453.HKD","BK4585","LU1719994722.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":0.1527},{"period":"3month","weight":-0.0562},{"period":"6month","weight":0.5989},{"period":"1year","weight":2.6237},{"period":"ytd","weight":2.6237}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"映恩生物是一家主要从事临床阶段生物制药的投资控股公司。该公司致力于为癌症和自身免疫性疾病等患者研发抗体偶联药物（ADC）创新药物。该公司的主要候选药物产品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。该公司的产品主要用于靶向治疗子宫内膜癌（EC）、乳腺癌（BC）、小细胞肺癌（SCLC）、去势抵抗性前列腺癌（CRPC）、食管鳞状细胞癌（ESCC）及头颈部鳞状细胞癌（HNSCC）。该公司主要在国内和国外市场开展业务。","exchange":"SEHK","name":"映恩生物-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"映恩生物-B,09606,映恩生物-B股票,映恩生物-B股票老虎,映恩生物-B股票老虎国际,映恩生物-B行情,映恩生物-B股票行情,映恩生物-B股价,映恩生物-B股市,映恩生物-B股票价格,映恩生物-B股票交易,映恩生物-B股票购买,映恩生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}